Since the loss of C/EBP-α in podocytes in vivo led to greater podocyte injury and aggravated kidney disease following ADR injection, we then sought to determine whether the elevated expression of C/EBP-α would be protective in podocyte injury. Here, CEBPA is linked to kidney disorder.